Veristat Launches AI Biostatistics Platform: Cutting Clinical Trial Data Readout Time from...
InStat™ delivers submission-ready tables, lists and figures (TLF) on validated statistical engines, with Clene Nanomedicine as its first...
Veristat Acquires Certara's Regulatory and Medical Writing Business
Veristat Expands Regulatory and Medical Writing Capabilities Through Acquisition of Certara’s Regulatory and Medical Writing Business
Veristat to Acquire Certara's Regulatory and Medical Writing Business
Strategic acquisition expands and enhances Veristat’s regulatory services to help more clinical trial sponsors develop novel, life-saving...
Veristat Expands Regulatory and Clinical Services to Chinese Drug and Device Companies...
International companies find a new, frictionless path to secure regional approvals in Veristat
Veristat Names Industry Veteran Kim McLean Boericke as New Chief Executive Officer
Boericke succeeds Patrick Flanagan, who is transitioning to the Board of Directors
Southborough, MA - Jan. 13, 2026 – Veristat, a global...
Veristat and AOBiome Therapeutics to Present at Clinical Outsourcing Group on Essential...
Southborough, MA - Oct. 7, 2025 – Veristat, a global clinical research organization (CRO) and consultancy specializing in complex studies,...
Cook MyoSite and Veristat Partner in Complex, Phase III, Adaptive Clinical Study of...
Veristat partners to achieve key enrollment milestone for study; activated 26 sites and enrolled over 100 participants
Veristat Achieves EcoVadis Committed Badge: A Milestone in Our Sustainability Journey
We're proud to announce that Veristat has received our first EcoVadis Committed Badge, marking a significant milestone in our commitment to...
Veristat Congratulates George Medicines on FDA Approval of WIDAPLIK™
Proud to Collaborate in Delivering a Groundbreaking, First-in-Class Therapy to Patients in Need
Veristat Appoints Industry Veteran Kim McLean Boericke as its Chief Operating Officer
Accelerating Operational Excellence and Client Success
SOUTHBOROUGH, MA – October 30, 2024—Veristat, a scientific-minded global clinical...
Veristat Appoints Gabriela Rosu, M.D., to Lead Growing Medical Affairs Team
To support sponsors around the globe bringing novel treatments to patients
SOUTHBOROUGH, MA – May 29, 2024 – Veristat, the Science-First...